Serum Positive for the Autoantibody against the β1-Adrenoceptor from Chinese Patients with Congestive Heart Failure Decreases Iss in Mouse Cardiac Myocytes by Wang, Yuan-yuan et al.
Hindawi Publishing Corporation
Clinicaland Developmental Immunology
Volume 2011, Article ID 143517, 7 pages
doi:10.1155/2011/143517
Research Article
SerumPositivefortheAutoantibodyagainsttheβ1-Adrenoceptor
fromChinesePatientswith CongestiveHeart FailureDecreases Iss
inMouse CardiacMyocytes
Yuan-yuanWang,1,2 Zhi-YongMa,1,2 Xiao-Dong Li,3 Jian-chunWang,3 Wei Zhang,1,2
LiLi,1,2 and YunZhang1,2
1Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of
Public Health, Jinan 250012, China
2Department of Cardiology, QiLu Hospital, Shandong University, Jinan 250012, China
3Department of Cardiology, Shandong Provincial Hospital, Shandong University, Jinan 250021, China
Correspondence should be addressed to
Li Li, lili 8599@163.com
Received 5 November 2010; Accepted 7 April 2011
Academic Editor: Stuart Mannering
Copyright © 2011 Yuan-yuan Wang et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Autoantibodies targeting the β1-adrenergic receptor (AAB-β1) display agonist-like eﬀects, which may have a pathogenic role in
the progression of heart failure. Here, we used the electrophysiological recordings to explore the eﬀects of AAB-β1-positive serum
from Chinese patients with heart failure on the activity of the peak transient outward potassium current (Ito) and the end 50 ms
steady-state potassium current (Iss) in mouse cardiac myocytes. We found that the AAB-β1-positive serum had no eﬀect on the
activity ofIto, but it produced adecrease in thecurrents ofIss.Alow concentrationofpositive serum (1/100)had asmallinhibitory
eﬀect on Iss. However, positive serum at 1:10, 1:20, and 1:50 signiﬁcantly decreased Iss. The concentration-dependence analysis
showed that the EC50 of AAB-β1-positive serum was 1/60.24 and its nH was 2.86. It indicated that the AAB-β1 could inhibit Iss in
mouse cardiomyocyte in a concentration-dependent manner.
1.Introduction
It has become increasingly clear that autoimmune disorders
a r eaf e a t u r eo fc o n g e s t i v eh e a r tf a i l u r e( C H F )o fv a r i o u s
etiologies [1, 2]. Over the past few decades, several autoan-
tibodies have been detected in the serum of patients with
CHF, including autoantibodies against α-adrenoceptor [3,
4], β1-adrenoceptor [5–9], and M2-adrenoceptor [10–12].
Autoantibodies targeting the second extracellular loop of the
β1-adrenergic receptor (AAB-β1) are speciﬁcally associated
with the eﬀects of β-blocker therapy and correct prediction
of ventricular tachycardia and sudden death in patients with
idiopathic dilated cardiomyopathy [8, 13]. In vivo, AAB-
β1can induce β1-adrenergic receptor uncoupling, which
causescardiomyocyteapoptosisandsustainedcalciuminﬂux
that results in cardiac electrical instability [14]. These results
suggest that AAB-β1 displays agonist-like eﬀects that may
have a pathogenic role in the progression of heart failure.
Additional evidence has revealed the electrophysiological
eﬀects of AAB-β1. AAB-β1 and the IgG fraction containing
this antibody signiﬁcantly enhanced Ica amplitude of adult
rat ventricular myocytes [15]. The previous study also
showed that puriﬁed autoantibodies enhanced cell short-
ening, prolonged action potential duration, and increased
calcium current amplitude of rat ventricular myocytes; these
positive eﬀects of AAB-β1 were indeed mediated via the
β1-adrenoceptor [14, 16]. However, the eﬀects of AAB-β1
on voltage-gated potassium channels in mouse ventricular
myocytes remained unclear.
In cardiac myocytes, voltage-gated K+ currents are
responsible for the repolarization of the membrane potential
and, therefore, inﬂuence action potential duration (APD).2 Clinical and Developmental Immunology
Previous studies have described a steady state outward
K+ current aside from the transient outward K+ current
in rat ventricular cells [17–19]. This steady state current
displayed a weak voltage-dependent inactivation and was
negativelyregulatedbytheβ-adrenergicagonistisoprenaline.
Thus, this steady state current might play an important
role in determining APD during neurohormonal regulation.
Therefore, we explored the eﬀects of AAB-β1-positive serum
from Chinese patients with CHF on the activity of the
peak transient outward potassium current (Ito) and the end
50ms steady state potassium current (Iss)i nm o u s ec a r d i a c
myocytes.
2.Materialsand Methods
2.1. Patients. Fourteen patients admitted to the Department
of Cardiology of QiLu Hospital of Shandong University
with stable CHF enrolled and submitted to serological tests,
coronary angiography, and electro- and echocardiography
to discard those with the following pathological condi-
tions: Chagas’ disease, hypertrophic cardiomyopathy, acute
coronary syndrome, severe hypertension, valvular heart
disease, alcohol or drug abuse, insulin-dependent diabetes
mellitus, and severe infection. All selected patients had left
ventricular ejection fractions (LVEF) ≤45% determined by
echocardiography (M mode). They were receiving standard
therapy,includingangiotensin-converting enzyme inhibitors
or angiotensin receptor blockers, diuretics, and digitalis
glycosides during the study. None of them were being
treated with β-blockers at enrollment. Five control sera were
obtained from voluntary healthy blood donors. The blood
was collected and fractioned, and the serum was stored
at −20◦C until immunological and/or electrophysiological
assays were performed. This study was performed in com-
pliance with the Declaration of Helsinki, and the protocol
was approved by the ethics committee of QiLu Hospital. All
patients gave informed consent for participation.
2.2. Autoantibodies. The target peptide was a fusion protein
corresponding to the putative sequence of the second extra-
cellular loop of the human β1-adrenergic receptor (amino
acids 197 to 222: H-W-W-R-A-E-S-D-E-A-R-R-C-Y-N-D-P-
K-C-C-D-F-V-T-N-R),whichwascommerciallysynthesized.
Peptidepuritywasascertainedbymassspectroscopyanalysis.
The presence of autoantibodies was determined by ELISA.
ELISA was carried out as previously described [12, 20]w i t h
the following modiﬁcations: the wells of microtiter plates
were coated with this peptide (10μg/mL) and incubated
for 2 hours. After washing the plate 3 times, 100μLo f
3% skim milk was added to each well for 2 hours. Then
100μL of patient serum (at dilutions starting from 1:20)
was added to the coated wells of the microtiter plate. After
washing the plate 3 times, an aﬃnity-puriﬁed antihuman
immunoglobulinGperoxidase-conjugatedantibody (diluted
1:5000) was added to each well for 1 hour. After washing the
plates 4 more times, bound peroxidase-conjugated antibody
were detected by incubation with the chromogenic substrate
for peroxidase. The reaction was stopped with 50μLo f
sulfuric acid, and the optical density was determined at
450nm. A positive reaction was deﬁned as ≥2.5 times the
background level. Autoantibodies directed against the β1-
adrenergic receptor were detected in 6 patients (43%) by
ELISA.
2.3. Cell Isolation. Ventricular myocytes were dissociated
f r o mt h eh e a r t so fm i c ea c c o r d i n gt op r e v i o u s l yp u b l i s h e d
protocol [14]. Brieﬂy, 8-week-old male Kunming mice (30–
40g) were anaesthetized with pentobarbitone sodium (30–
40mg/kg), which were injected intravenously together with
heparin (100IU/kg). The heart was removed, washed in
a cold calcium-free Joklik MEM (Sigma) solution, and
perfused for5minonaLangendorﬀapparatuswith thesame
calcium-free Joklik MEM (containing 11.0g/L Joklik MEM
and 10mmol/L HEPES, the pH was adjusted to 7.3 with
NaOH) warmed to 37◦C. The heart was then perfused with
collagenase-containing solution(collagenase,1mg/mL, Wor-
thington, and BSA 1mg/mL). After approximately 15min,
the ventricles were removed, placed in fresh solution, cut
into 1mm3 sections, and gently agitated to dissociate the
myocytes. Single ventricular myocytes were collected in KB
solution (composition in mM: 30 KCl, 35 KOH, 3 MgSO4,
50 L-glutamic acid, 0.5 EGTA, 20 taurine, 10 glucose, and 10
HEPES; pH adjusted to 7.2 with KOH). Cells were stored at
22–24◦C.
2.4. Electrophysiological Recordings. The cardiac myocytes
were transferred to a recording chamber mounted on an
inverted microscope (NIKON TE2000-U) at least 10min
before patch clamping. Micropipettes were made from
borosilicate glass capillary with an outside diameter of
1.5mm. After being ﬁre-polished and ﬁlled with pipette
solution (composition in mM: 115 K-aspartate, 5 KCl,
4N a 2ATP, 7 MgCl2,5E G T A ,a n d1 0H E P E S ;p Hw a s
adjusted with NaOH to 7.2), the resistance was 2–4MΩ.
The junction potential between the patch pipettes and bath
solutionwasnulliﬁedimmediatelybeforeGΩsealformation.
Cell capacitances were read from the potentiometer to set
transient capacitances to zero. After the pipette and cell
transient capacitance were compensated, the membrane
was ruptured with gentle suction to obtain the whole
cell voltage-clamp conﬁguration using PCS-5200 micro-
operation (Burleigh, USA). Signals were ampliﬁed with
HEKA EPC-10 patch clamp ampliﬁer and controlled with
the Pulse software (HEKA, Lambrecht, Germany). Signals
were sampled at 3kHz and ﬁltered at 1kHz. The voltage
protocol was a 1-s depolarizing step from −50 to +50mV
in 10mV increments from a holding potential of −60mV.
The peak of the current was the transient outward potassium
channel current (Ito) ,a n dt h ee n d5 0m so fp l a t e a up o t e n t i a l
current was Iss. All experiments were performed at room
temperature (22–25◦C). The ventricular myocytes were
perfused with normal bath solution (BS, composition in
mM: 135 ChCl, 5.4 KCI, 1.2 MgCl2, 0.5 CdCl, 10 glucose,
and 10 HEPES; pH was adjusted to 7.4 with NaOH) for
10min to stabilize the currents. For analysis of autoantibodyClinical and Developmental Immunology 3
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Figure 1: Eﬀect of AAB-β1-negative and -positive serum of CHF patients on outward K+ currents of mouse cardiomyocytes: (a), (b), (c),
and (d), current traces obtained with 1-s depolarizing step from −5 0t o+ 5 0m Vi n1 0m Vi n c r e m e n t sf r o mah o l d i n gp o t e n t i a lo f−60mV.
Voltageprotocolsareshownbelow thecurrent traces.Under thepresentexperimental conditions,thepeak ofthecurrent wasIto,andtheend
50msofplateau potential current wasIss. (e),(f),corresponding current–voltage relationshipsduring the applicationofAAB- β1-negative or
-positive serum of CHF patients atthe dilution of 1:20. AAB-β1 negative serum had no eﬀect on the activity of Ito, Iss andthe corresponding
current-voltage curves (b, d, e, f). The AAB- β1-positive serum had no eﬀect on activity of Ito, but it produced a decrease in the currents of
Iss ( a ,c ,e ,f) .
eﬀects,cellswereseparatelyperfused withBSincludingAAB-
β1-negative serum and AAB-β1-positive serum for 5min.
For the concentration-dependence analysis of autoantibody
eﬀects, cells were perfused with the following bath solutions:
serum dilution ranging from 1/100, 1/50, 1/20 to 1/10.
The recordings were analyzed using IGOR and the
Origin software. The value of current was expressed with
the density of current (pA/pF) to eliminate the capacitance
error. Current amplitude was determined as the diﬀerence
between peak inward current and current at the end of the
depolarising step.
2.5. Statistics. All of the data were presented as the means ±
S.E. One-way ANOVA with repeated measures and analysis
of variance were used for statistical analysis where appro-
priate. Statistical analysis was performed using the SPSS12.0
software, and P<. 05 was considered statistically signiﬁcant.
AAB-β1-positive serum dilution-response curves were ﬁtted
using the equation: I = a/(1 + (EC50/dilution)
nH ), where
a was the amplitude of the Iss current, the EC50 was the
dilutionwhereahalf-maximal responsewasinduced,andnH
was the Hill coeﬃcient.
3.Results
Under these experimental conditions (in the presence of
ChCl and CdCl to block the Na+ currents and Ca2+ cur-
rents, resp.), outward K+ currents were recorded in mouse
myocytes. These readings were composed of rapidly activat-
ing and inactivating currents (Ito) and slowly activating but
noninactivating current (Iss)( Figure 1(a), 1(b), 1(c), 1(d)).
The AAB-β1-negative serum of CHF patients had no
eﬀect on the activity of Ito and Iss in mouse ventricular
myocytes (Figures 1(b) and 1(d)). The negative serum also4 Clinical and Developmental Immunology
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Figure 2: Comparison of AAB-β1-negative serum and -positive serum from patients with heart failure (dilution at 1:20) on the mean
current of outward K+ currents at a voltage of 50mV. Compared to currents at normal bath solution and AAB-β1-negative serum (n = 5
cells,dilutionat1:20),AAB-β1-positive serum(n = 7cells,dilutionat1:20)hadnoeﬀect onIto (P>. 05).Iss ontheAAB-β1-positive serum
decreased signiﬁcantly compared to the normal bath solution (P<. 05) and had also signiﬁcant decrease compared to the AAB-β1-negative
serum (P<. 05).
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Figure 3: Diﬀerent concentrations of AAB-β1-positive serum (dilution ranging from 1:100, 1:50, 1:20 to 1:10) on the outward
K+ currents at a voltage of 50mV: Ito showed no changes at diﬀerent concentrations of AAB-β1-positive serum (a). A low concentration
of AAB-β1-positive serum (1:100) had a small inhibitory eﬀect on Iss (b, c). However, AAB-β1-positive serum at 1:10, 1:20, and 1:50
signiﬁcantly decreased Iss (P<. 05, b, c). Additionally, there were no signiﬁcant diﬀerences in currents at 1/10 and 1/20 AAB-β1-positive
serum treatment (b, c). AAB-β1-positive serum had no eﬀect on the I-V relationship at any concentration (a, b). ∗P<. 05.Clinical and Developmental Immunology 5
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Figure 4: Concentration-dependent inhibition of AAB-β1-positive
serum on Iss activated at a potential of 50mV: EC50 (dilution of
AAB-β1 positive serum that produces the half-maximumblockade)
of AAB-β1-positive serum was 1:60.24 and nH was 2.86.
showed no eﬀect on the current-voltage curves of Ito and Iss
(Figures 1(e) and 1(f)). The AAB-β1-positive serum had no
eﬀect on activity of Ito, but it produced a decrease in the
currents of Iss (Figure 1(a), 1(c), 1(e), 1(f)). Compared to
the currents at normal bath solution and AAB-β1-negative
serum (dilution at 1:20), AAB-β1-positive serum (dilution
at 1:20) had no eﬀectonIto but caused a signiﬁcant decrease
in Iss myocyte currents (P<. 05, Figure 2).
Compared with the normal bath solution, the current
densityofIto showednochangeatdiﬀerentconcentrationsof
AAB-β1-positiveserum(Figure 3(a)).Alowconcentrationof
AAB-β1-positive serum (1/100) had a small inhibitory eﬀect
on Iss (Figures 3(b) and 3(c)). However, AAB-β1-positive
serum at 1:10, 1:20 and 1:50 signiﬁcantly decreased Iss
(P<. 05, Figures 3(b) and 3(c)). Additionally, there were
no signiﬁcant diﬀerences in the Iss currents between 1/10
and 1/20 AAB-β1-positive serum (Figures 3(b) and 3(c))
treatments. Similarly, AAB-β1-positive serum had no eﬀect
on the I-V relationship at any concentration (Figures 3(a)
and 3(b)). The concentration-dependence analysis showed
that the EC50 of AAB-β1-positive serum was 1/60.24, and its
nH was 2.86 (Figure 4).
4.Discussion
Increasing evidence demonstrates that the contribution of
AAB-β1 to the pathogenesis of chronic heart failure is not
just a correlation. In the present study, we found for the
ﬁrst time that serum positive for autoantibodies against
the β1-adrenoceptor decreases the current density of Iss in
mouse ventricular myocytes in a concentration-dependent
manner, with no eﬀect on Ito. AAB-β1-positive serum at the
dilution of 1:10, 1:20, and 1:50 signiﬁcantly decreased Iss.
Concentration-dependence analysis showed that the EC50
was 1/60.24 and nH was 2.86.
The autoantibodies for the β1-adrenergic receptor have
been found in sera not only from patients with idiopathic
dilatedcardiomyopathy [5],butalso frompatientswith CHF
of various etiologies [21, 22]. Previous studies have conclu-
sively demonstrated that autoantibodies targeting the second
extracellular loop of the β1-adrenergic receptor showed
agonist-like eﬀects: inducing receptor uncoupling, causing
cardiomyocyte apoptosis, and permitting sustained calcium
inﬂux [14, 23]. In the present study, serum positive for
autoantibodies against the β1-adrenoceptor decreased the
current density of Iss without any eﬀect on Ito,w h i c hi s
similar to the inhibitory eﬀect of the β1-adrenergic agonist
isoprenaline [17]. From this close resemblance of macro-
scopicIss after stimulationwith AAB-β1 and isoprenaline, we
suggest that both activators mediate their eﬀects via similar
signal transduction pathways.
Autoantibodies are thought to induce activation of the
receptor that leads to intracellular signaling involving the
classical PKA pathway [24–27]. Other groups have reported
eﬀects of puriﬁed autoantibodies or AAB-β1-positive serum
on calcium channels. Christ et al. found that immunoglobu-
lin G derived from patients positive for the β1-adrenoceptor
autoantibodies increased Ca2+ current to a similar extent,
but prolonged the plateau of duration of action potentials
to a lesser extent compared to isoprenaline [14]. However,
Del Corsso et al. found that serum from patients with IDC
induced a signiﬁcant decrease in isoproterenol-stimulated
L-type Ca2+ currents in rabbit ventricular myocytes. This
activation is known to involve the PKA pathway [12].
Furthermore, Christ et al. concluded that AAB-β1 may not
only enhance ICa via stimulation of the β1-adrenoceptors,
but may also inhibit this β1-adrenoceptor-mediated increase
upon stimulation with catecholamines [16]. In our study,
AAB-β1-positive serum inhibited Iss in a concentration-
dependent manner with no eﬀect on the current-voltage
curves. Therefore, the regulatory eﬀect of AAB-β1on ion
channel currents may all involve the classical PKA pathway
in the diﬀerent studies.
Furthermore, AAB-β1-positive serum only decreased Iss
with no eﬀect on Ito, which was similar to the results of
β1-adrenergic agonist isoprenaline treatment [17]. Several
hypotheses can be proposed to account for such a diﬀerence
in threshold dose and potency. The channels may be more
easily accessible to phosphorylation in Iss than Ito,w h i c h
is a possible eﬀect according to the theory of cAMP com-
partmentalization. Another possibility is that the channels
may be more sensitive to phosphorylation in Iss than Ito;f o r
example, phosphorylation at one site on Iss may be suﬃcient
to induce an eﬀect while Ito requires phosphorylation of
several sites. The above suggested mechanisms may also lead
to the dose-dependence of Iss.
5.Conclusions
Autoantibodies against β1-adrenoceptor from Chinese
patients with congestive heart failure can inhibit Iss in mouse
cardiomyocytes in a concentration-dependent manner.
Because Iss plays an important role in the repolarization of
action potentials, AAB-β1 may inﬂuence action potential
duration via this current.6 Clinical and Developmental Immunology
5.1. Study Limitations and Clinical Implications. In the
present study, we did not investigate the mechanism behind
the inhibitory eﬀect of AAB-β1on Iss. It would require much
more work to establish whether AAB-β1 inhibits Iss directly
or indirectly. Recent studies reported that AAB-β1 may
inﬂuence the eﬀects of β-blocker therapy and that speciﬁc
removal of AAB-β1 by immunoadsorption can improve
cardiac function in patients with DCM. These results
suggest that anti-β1-adrenergic receptor autoantibodies have
a pathogenic role in the onset and progression of heart
failure. Because Iss has biophysical properties of being slowly
activated and noninactivated (steady state), AAB-β1 may
prolong repolarization and action potential duration by
inhibiting Iss; this would subsequently result in cardiac
electrical instability.
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